Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Keith Al-Hasani is active.

Publication


Featured researches published by Keith Al-Hasani.


web science | 2000

The sigA gene which is borne on the she pathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation.

Keith Al-Hasani; Ian R. Henderson; Harry Sakellaris; Kumar Rajakumar; Travis Grant; James P. Nataro; Roy M. Robins-Browne; Ben Adler

ABSTRACT In this study, the sigA gene situated on theshe pathogenicity island of Shigella flexneri2a was cloned and characterized. Sequence analysis showed thatsigA encodes a 139.6-kDa protein which belongs to the SPATE (serine protease autotransporters of Enterobacteriaceae) subfamily of autotransporter proteins. The demonstration that SigA is autonomously secreted from the cell to yield a 103-kDa processed form and possesses a conserved C-terminal domain for export from the cell were consistent with the autotransporter pathway of secretion. Functional analysis showed that SigA is a secreted temperature-regulated serine protease capable of degrading casein. SigA was cytopathic for HEp-2 cells, suggesting that it may be a cell-altering toxin with a role in the pathogenesis ofShigella infections. SigA was at least partly responsible for the ability of S. flexneri to stimulate fluid accumulation in ligated rabbit ileal loops.


Veterinary Microbiology | 2010

Outer membrane proteins of Pasteurella multocida.

Tamás Hatfaludi; Keith Al-Hasani; John D. Boyce; Ben Adler

Pasteurella multocida is a ubiquitous pathogen which causes a range of diseases in diverse animal species. Components of the bacterial outer membrane, such as trans membrane proteins and lipoproteins, play key roles in the interaction of the pathogen with the host environment and in the host immune response to infection. In this review, we evaluate the current knowledge of P. multocida outer membrane proteins and their role in pathogenesis and immunity.


Nature Biotechnology | 2007

Genome sequence and identification of candidate vaccine antigens from the animal pathogen Dichelobacter nodosus

Garry Myers; Dane Parker; Keith Al-Hasani; Ruth M. Kennan; Torsten Seemann; Qinghu Ren; Jonathan H. Badger; Jeremy D. Selengut; Robert T. DeBoy; Hervé Tettelin; John D. Boyce; Victoria P McCarl; Xiaoyan Han; William C. Nelson; Ramana Madupu; Yasmin Mohamoud; Tara Holley; Nadia Fedorova; Hoda Khouri; Steven P Bottomley; Richard J. Whittington; Ben Adler; J. Glenn Songer; Julian I. Rood; Ian T. Paulsen

Dichelobacter nodosus causes ovine footrot, a disease that leads to severe economic losses in the wool and meat industries. We sequenced its 1.4-Mb genome, the smallest known genome of an anaerobe. It differs markedly from small genomes of intracellular bacteria, retaining greater biosynthetic capabilities and lacking any evidence of extensive ongoing genome reduction. Comparative genomic microarray studies and bioinformatic analysis suggested that, despite its small size, almost 20% of the genome is derived from lateral gene transfer. Most of these regions seem to be associated with virulence. Metabolic reconstruction indicated unsuspected capabilities, including carbohydrate utilization, electron transfer and several aerobic pathways. Global transcriptional profiling and bioinformatic analysis enabled the prediction of virulence factors and cell surface proteins. Screening of these proteins against ovine antisera identified eight immunogenic proteins that are candidate antigens for a cross-protective vaccine.


PLOS ONE | 2009

The immunogenic SigA enterotoxin of Shigella flexneri 2a binds to HEp-2 cells and induces fodrin redistribution in intoxicated epithelial cells.

Keith Al-Hasani; Fernando Navarro-Garcia; Jazmin Huerta; Harry Sakellaris; Ben Adler

Background We have previously shown that the enterotoxin SigA which resides on the she pathogenicity island (PAI) of S. flexneri 2a is an autonomously secreted serine protease capable of degrading casein. We have also demonstrated that SigA is cytopathic for HEp-2 cells and plays a role in the intestinal fluid accumulation associated with S. flexneri infections. Methods/Principal Findings In this work we show that SigA binds specifically to HEp-2 cells and degrades recombinant human αII spectrin (α-fodrin) in vitro, suggesting that the cytotoxic and enterotoxic effects mediated by SigA are likely associated with the degradation of epithelial fodrin. Consistent with our data, this study also demonstrates that SigA cleaves intracellular fodrin in situ, causing its redistribution within cells. These results strongly implicate SigA in altering the cytoskeleton during the pathogenesis of shigellosis. On the basis of these findings, cleavage of fodrin is a novel mechanism of cellular intoxication for a Shigella toxin. Furthermore, information regarding immunogenicity to SigA in infected patients is lacking. We studied the immune response of SigA from day 28 post-challenge serum of one volunteer from S. flexneri 2a challenge studies. Our results demonstrate that SigA is immunogenic following infection with S. flexneri 2a. Conclusions This work shows that SigA binds to epithelial HEp-2 cells as well as being able to induce fodrin degradation in vitro and in situ, further extending its documented role in the pathogenesis of Shigella infections.


Microbial Cell Factories | 2007

Identification of novel immunogens in Pasteurella multocida

Keith Al-Hasani; John D. Boyce; Victoria P McCarl; Stephen Bottomley; Ian Wilkie; Ben Adler

P. multocida is a Gram-negative pathogen responsible for causing diseases in animals of economic significance to livestock industries throughout the world. Current vaccines include bacterins, which provide only limited protection against homologous serotypes. Therefore there is a need for more effective vaccines to control diseases caused by P. multocida. As a step towards developing vaccines against fowl cholera, a genomics based approach was applied for the identification of novel immunogens.ResultsBioinformatics analysis of the P. multocida genome predicted 129 proteins as secreted, located in the outer membrane, or lipoproteins. 105 of the genes encoding these proteins were cloned and recombinant protein expressed in Escherichia coli. Polyclonal serum from P. multocida-infected chickens reacted with a subset of these proteins.ConclusionThese data show the range of bacterial immunogens recognized by the chicken immune system, including 6 novel immunoreactive proteins.


PLOS ONE | 2012

Screening of 71 P. multocida Proteins for Protective Efficacy in a Fowl Cholera Infection Model and Characterization of the Protective Antigen PlpE

Tamas Z Hatfaludi; Keith Al-Hasani; Lan Gong; John D. Boyce; Mark Ford; Ian Wilkie; Noelene S. Quinsey; Michelle Anne Dunstone; David E. Hoke; Ben Adler

Background There is a strong need for a recombinant subunit vaccine against fowl cholera. We used a reverse vaccinology approach to identify putative secreted or cell surface associated P. multocida proteins that may represent potential vaccine candidate antigens. Principal Findings A high-throughput cloning and expression protocol was used to express and purify 71 recombinant proteins for vaccine trials. Of the 71 proteins tested, only one, PlpE in denatured insoluble form, protected chickens against fowl cholera challenge. PlpE also elicited comparable levels of protection in mice. PlpE was localized by immunofluorescence to the bacterial cell surface, consistent with its ability to elicit a protective immune response. To explore the role of PlpE during infection and immunity, a plpE mutant was generated. The plpE mutant strain retained full virulence for mice. Conclusion These studies show that PlpE is a surface exposed protein and was the only protein of 71 tested that was able to elicit a protective immune response. However, PlpE is not an essential virulence factor. This is the first report of a denatured recombinant protein stimulating protection against fowl cholera.


Molecular Microbiology | 2004

Regulated site‐specific recombination of the she pathogenicity island of Shigella flexneri

Harry Sakellaris; Shelley N. Luck; Keith Al-Hasani; Kumar Rajakumar; Sally A. Turner; Ben Adler

Summary The she pathogenicity island (PAI) is a chromosomal, laterally acquired, integrative element of Shigella flexneri that carries genes with established or putative roles in virulence. We demonstrate that spontaneous, precise excision of the element from its integration site in the 3′ terminus of the pheV tRNA gene is mediated by an integrase gene (int) and a gene designated rox (regulator of excision), both of which are carried on the she PAI. Integrase‐mediated excision occurs via recombination between a 22 bp sequence at the 3′ terminus of pheV and an imperfect direct repeat at the pheV‐distal boundary of the PAI. Excision leads to the formation of a circular episomal form of the PAI, reminiscent of circular excision intermediates of other mobile elements that are substrates for lateral transfer processes such as conjugation, packaging into phage particles and recombinase‐mediated integration into the chromosome. The circle junction consists of the pheV‐proximal and pheV‐distal boundaries of the PAI converging on a sequence identical to 22 bp at the 3′ terminus of pheV. The isolated circle was transferred to Escherichia coli where it integrated specifically into phe tRNA genes, as it does in S. flexneri, independently of recA. We also demonstrate that Rox stimulates, but is not essential for, excision of the she PAI in an integrase‐dependent manner. However, Rox does not stimulate excision by activating the transcription of the she PAI integrase gene, suggesting that it has an excisionase function similar to that of a related protein from the P4 satellite element of phage P2.


Journal of Medical Microbiology | 2001

Distribution and structural variation of the she pathogenicity island in enteric bacterial pathogens

Keith Al-Hasani; Ben Adler; Kumar Rajakumar; Harry Sakellaris

Shigella flexneri serotype 2a carries a chromosomal pathogenicity island (PAI), termed the she PAI, that has been implicated in the pathogenesis of diarrhoeal disease. The complete nucleotide sequence and genetic organisation of the she PAI of S. flexneri 2a strain YSH6000T was determined recently. In the current study the distribution and structure of the she PAI was investigated by PCR and Southern analysis in 65 isolates of enteric pathogens including Shigella spp., enterohaemorrhagic Escherichia coli (EHEC), enteropathogenic E. coli (EPEC), enteroinvasive E. coli (EIEC), Yersinia enterocolitica and Salmonella enterica serovar Typhimurium. The study showed that the she PAI has undergone a variety of structural changes, defined by the presence or absence of specific marker genes in the PAI. The she PAI or structural variants of this element were found in all species of Shigella as well as in EIEC, EHEC and EPEC. No evidence of the PAI was found in Y. enterocolitica or Sal. Typhimurium. The structural form of the she PAI that exists in strain YSH6000T was present in all strains of S. flexneri serotype 2a and in some strains of S. flexneri serotypes 2b and 3c. Variants of the PAI that were missing one or more marker regions were found in all species of Shigella and in pathogenic strains of E. coli. In all strains, the PAIs have inserted into either pheV or a phe tRNA gene in another location on the chromosome. It was concluded that the she PAI is one of several closely related genetic elements that have disseminated throughout Shigella and pathogenic strains of E. coli and diverged into distinct stuctural forms.


PubMed | 2004

Regulated site-specific recombination of the she pathogenicity island of Shigella flexneri.

Harry Sakellaris; Shelley N. Luck; Keith Al-Hasani; Kumar Rajakumar; Sally A. Turner; Ben Adler

Summary The she pathogenicity island (PAI) is a chromosomal, laterally acquired, integrative element of Shigella flexneri that carries genes with established or putative roles in virulence. We demonstrate that spontaneous, precise excision of the element from its integration site in the 3′ terminus of the pheV tRNA gene is mediated by an integrase gene (int) and a gene designated rox (regulator of excision), both of which are carried on the she PAI. Integrase‐mediated excision occurs via recombination between a 22 bp sequence at the 3′ terminus of pheV and an imperfect direct repeat at the pheV‐distal boundary of the PAI. Excision leads to the formation of a circular episomal form of the PAI, reminiscent of circular excision intermediates of other mobile elements that are substrates for lateral transfer processes such as conjugation, packaging into phage particles and recombinase‐mediated integration into the chromosome. The circle junction consists of the pheV‐proximal and pheV‐distal boundaries of the PAI converging on a sequence identical to 22 bp at the 3′ terminus of pheV. The isolated circle was transferred to Escherichia coli where it integrated specifically into phe tRNA genes, as it does in S. flexneri, independently of recA. We also demonstrate that Rox stimulates, but is not essential for, excision of the she PAI in an integrase‐dependent manner. However, Rox does not stimulate excision by activating the transcription of the she PAI integrase gene, suggesting that it has an excisionase function similar to that of a related protein from the P4 satellite element of phage P2.


Transgenic Research | 2004

Complementation of α-thalassaemia in α-globin Knockout Mice with a 191 kb Transgene Containing the Human α-Globin Locus

Keith Al-Hasani; Jim Vadolas; Lucille Voullaire; Robert Williamson; Panayiotis A. Ioannou

Abstractα-Thalassaemia is an inherited blood disorder caused by a decrease in the synthesis of α-globin due to mutations in one or both of the α-globin genes located on human chromosome 16. A 191 kb transgene derived from a sequenced bacterial artificial chromosome (BAC) clone carrying the human α-globin gene cluster, together with about 100 kb of sequence upstream of DNase1 hypersensitive site HS-40 and 30 kb downstream of the α1-globin gene, was introduced into fertilised mouse oocytes by pronuclear microinjection. Three transgenic founder mice were obtained. Analysis of one transmitting line by fluorescent in situ hybridisation and quantitative PCR demonstrated a single copy integration of the human α-globin transgene on chromosome 1. Analysis of haemoglobins from the peripheral blood by cellulose acetate electrophoresis and high performance liquid chromatography (HPLC) demonstrated synthesis of human α-globin to about 36% of the level of each mouse α-globin locus. Breeding of transgenic mice with mice heterozygous for a knockout (KO) deletion of both murine α-globin genes showed that the human α-globin locus restored haemoglobin levels and red cell distribution width to normal in double heterozygous mice and significantly normalised other haematological parameters. Interestingly the human transgene also induced a significant increase in red cell production and haematocrit above wild type values. This is the first report demonstrating complementation of a murine α-globin KO mutation by human α-globin gene expression from an intact human α-globin locus. The transgenic mouse model described in this report should be very useful for the study of human α-globin gene regulation and for the development of strategies to down regulate α-globin production as a means of ameliorating the severity of β-thalassaemia.

Collaboration


Dive into the Keith Al-Hasani's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Victoria P McCarl

Australian Research Council

View shared research outputs
Top Co-Authors

Avatar

Ian Wilkie

University of Queensland

View shared research outputs
Top Co-Authors

Avatar

Jim Vadolas

Royal Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge